Orphan Nuclear Receptor Nurr1 as a Potential Novel Marker for Progression in Human Prostate Cancer

  • Wang, Jian (Sino-American Cancer Research Institute, Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Guangdong Medical College) ;
  • Yang, Jing (Department of Biochemistry, Liaoning Medical College) ;
  • Zou, Ying (Sino-American Cancer Research Institute, Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Guangdong Medical College) ;
  • Huang, Guo-Liang (Sino-American Cancer Research Institute, Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Guangdong Medical College) ;
  • He, Zhi-Wei (Sino-American Cancer Research Institute, Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Guangdong Medical College)
  • 발행 : 2013.03.30


A number of studies have indicated that Nurr1, which belongs to a novel class of orphan nuclear receptors (the NR4A family), is important for carcinogenesis. Here we investigated expression of Nurr1 protein in benign and malignant human prostate tissues and association with clinicopathologic features using immunohistochemical techniques. Moreover, we also investigated the ability of Nurr1 to influence proliferation, migration, invasion and apoptosis of human prostate cancer cells using small interfering RNA silencing. Immunohistochemical analysis revealed that the expression of Nurr1 protein was higher in prostate cancer tissues than in benign prostate tissue (P<0.001), levels being positively correlated with tumor T classification (P = 0.003), N classification (P = 0.017), M classification (P = 0.011) and the Gleason score (P = 0.020) of prostate cancer patients. In vitro, silencing of endogenous Nurr1 attenuated cell proliferation, migration and invasion, and induced apoptosis of prostate cancer cells. These results suggest that Nurr1 may be used as an indicator for prostate cancer progression and be useful for novel potential therapeutic strategies.


연구 과제 주관 기관 : Guangdong Natural Science Foundation


  1. Namiki M, Akaza H, Lee SE, et al (2010). Prostate Cancer Working Group report. Jpn J Clin Oncol, 40, 70-5.
  2. Pei L, Castrillo A, Chen M, Hoffmann A, Tontonoz P (2005). Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. J Biol Chem, 280, 29256-62.
  3. Pols TW, Bonta PI, de Vries CJ (2007). NR4A nuclear orphan receptors: protective in vascular disease? Curr Opin Lipidol, 18, 515-20.
  4. Shariat SF, Semjonow A, Lilja H, et al (2011). Tumor markers in prostate cancer I: blood-based markers. Acta Oncol, 50, 61-75.
  5. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.
  6. Sirin O, Lukov GL, Mao R, Conneely OM, Goodell MA (2010). The orphan nuclear receptor Nurr1 restricts the proliferation of haematopoietic stem cells. Nat Cell Biol, 12, 1213-9.
  7. Soumaoro LT,Uetake H, Higuchi T, et al (2004). Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin Cancer Re, 10, 8465-71.
  8. Sousa KM,Mira H, Hall AC, et al (2007). Microarray analyses support a role for Nurr1 in resistance to oxidative stress and neuronal differentiation in neural stem cells. Stem Cells, 25, 511-9.
  9. Zeng H, Qin L, Zhao D, et al (2006). Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity. J Exp Med, 203, 719-29.
  10. Maijenburg MW, Gilissen C, Melief SM, et al (2012). Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migration. Stem Cells Dev, 21, 228-38.
  11. Nomiyama T, Nakamachi T, Gizard F, et al (2006). The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation. J Biol Chem, 281, 33467-76.
  12. Bonta PI, van Tiel CM, Vos M, et al (2006). Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler Thromb Vasc Biol, 26, 2288-94.
  13. Bonta PI, Pols TW, van Tiel CM, et al (2010). Nuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammation. Circulation, 121, 2023-32.
  14. Bjartell A, Montironi R, Berney DM, Egevad L (2011). Tumour markers in prostate cancer II: diagnostic and prognostic cellular biomarkers. Acta Oncol, 50, 76-84.
  15. Cao JY, Liu L, Chen SP, et al (2010). Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma. Mol Cancer, 9, 237.
  16. Dassesse T, de Leval X, de Leval L, et al (2006). Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage. Eur Urol, 50, 1021-31.
  17. Hsu HC, Zhou T, Mountz JD (2004). Nur77 family of nuclear hormone receptors. Curr Drug Targets Inflamm Allergy, 3, 413-23.
  18. Holla VR, Mann JR, Shi Q, DuBois RN (2006). Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. J Biol Chem, 281, 2676-82.
  19. Inamoto T, Czerniak BA, Dinney CP, Kamat AM (2010). Cytoplasmic mislocalization of the orphan nuclear receptor Nurr1 is a prognostic factor in bladder cancer. Cancer, 116, 340-6.
  20. Ke N, Claassen G, Yu DH, et al (2004). Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis. Cancer Res, 64, 8208-12.
  21. Li X, Tai HH (2009). Activation of thromboxane A2 receptors induces orphan nuclear receptor Nurr1 expression and stimulates cell proliferation in human lung cancer cells. Carcinogenesis, 30, 1606-13.
  22. Lee HS, Bae EJ, Yi SH, et al (2010). Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function, and cell survival. Stem Cells, 28, 501-12.
  23. Zhang T, Wang P, Ren H, Fan J, Wang G (2009). NGFI-B nuclear orphan receptor Nurr1 interacts with p53 and suppresses its transcriptional activity. Mol Cancer Re, 7, 1408-15.
  24. Zhao Y, Bruemmer D (2010). NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology. Arterioscler Thromb Vasc Biol, 30, 1535-41.
  25. Zhou X, Lawrence TJ, He Z, et al (2012). The expression level of lysophosphatidylcholine acyltransferase 1 (LPCAT1) correlates to the progression of prostate cancer. Exp Mol Pathol, 92, 105-10.

피인용 문헌

  1. Red Cell Distribution Width as a Predictor of Prostate Cancer Progression vol.15, pp.18, 2014,
  2. Nuclear Ep-ICD Expression Is a Predictor of Poor Prognosis in “Low Risk” Prostate Adenocarcinomas vol.10, pp.2, 2015,
  3. The NR4A orphan nuclear receptors: mediators in metabolism and diseases vol.35, pp.2, 2015,
  4. Orphan nuclear receptor Nurr1 as a potential novel marker for progression in human pancreatic ductal adenocarcinoma vol.13, pp.2, 2016,
  5. Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer vol.16, pp.1, 2016,
  6. Effects of nitrogen on the apoptosis of and changes in gene expression in human lymphoma U937 cells exposed to argon-based cold atmospheric pressure plasma vol.37, pp.6, 2016,
  7. Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer vol.25, pp.1, 2017,
  8. Clinical implications of pretreatment inflammatory biomarkers as independent prognostic indicators in prostate cancer pp.08878013, 2017,
  9. Nuclear receptors in cancer — uncovering new and evolving roles through genomic analysis vol.19, pp.3, 2017,
  10. Molecular Insights into NR4A2(Nurr1): an Emerging Target for Neuroprotective Therapy Against Neuroinflammation and Neuronal Cell Death pp.1559-1182, 2019,